记者从工业和信息化部网站了解到，经省级主管部门推荐、专家评价、面向社会公示等程序，首批 生物制造中试能力建设平台名单公布，全国共有43家平台入选。其中山东齐鲁制药有限公司(生物制药 方向）、山东隆科特酶制剂有限公司（酶制剂方向）、山东大学（食品及添加剂、酶制剂方向）入选。 聚焦食品及添加剂、生物制药、化妆品、化工、能源、酶制剂等重点产品领域，工信部提出开展生 物制造中试能力建设平台培育，带动产业链上下游协同创新发展。列入名单的平台需聚焦相应服务领 域，持续加大资源投入力度，强化软硬件建设和专业人才培养，提升平台对外开放和中试服务水平。工 信部将按年度组织专家对列入名单的平台软硬件水平、对外开展中试服务的数量及质效等方面进行评 估，动态调整平台服务能力星级，对服务能力、服务效果达不到要求以及知识产权、安全生产、环境保 护、质量安全等方面出现严重违法违规情况的平台予以除名。（记者 付玉婷） ...

本周流感活动水平出现下降，甲型H3N2为主要毒株 国家卫健委12月19日举行新闻发布会，专家介绍，当前我国呼吸道传染病疫情仍然处于高发季节。从中国疾控中心发布 的监测报告来看，流感病毒是我国急性呼吸道传染病主要流行的病原体，呼吸道合胞病毒、鼻病毒亦存在一定水平的活 动。本周我国流感活动水平出现下降，但是总体仍处于高流行水平。从哨点医院流感病毒检测阳性率情况来看，门急诊 流感样病例和住院的严重呼吸道感染病例当中，流感病毒检测阳性率均居首位。甲型H3N2为主要的流感毒株。从各省 监测情况来看，南方部分省份疫情达峰时间略晚于北方。总体来看，各省份流行强度处于动态变化之中，请大家重视并 做好个人和家人的防护措施。 医保局："医保影像云"四项规范向社会征求意见 据国家医保局网站12月19日消息，为解除群众疾病医疗后顾之忧，更好维护医保参保人权益，国家医保局依托全国医保 信息平台，组织开展医保影像云系列规范研究，制定形成了四项《"医保影像云"基础规范》，公开征求社会意见。本次 规范编制的核心目标是加快推进医保影像云高质量建设，构建影像检查数据全国存储、机构调阅、参保人查阅的数字化 服务平台，支撑全国定点医疗机构间医保支付 ...

Group 1 - The event "Future Industry Special Session of Science Café: Construction and Application of Synthetic Biology Pilot Platforms" was held in Hangzhou, gathering nearly 50 representatives from government, pilot platforms, enterprises, investment institutions, and research institutes to discuss the construction of pilot platforms in synthetic biology manufacturing and industry collaboration development [1][2] - The pilot platform serves as a crucial bridge between laboratory research and large-scale production, providing engineering and product validation to mitigate technology transfer risks and support industrial implementation [1][2] - The Ministry of Industry and Information Technology announced the first batch of 43 selected pilot platforms nationwide, with three units from Zhejiang, including the National Science Wenzhou Research Institute, Zhejiang Marine Development Research Institute, and Hangzhou Chuanhua Technology City Co., Ltd [1][2] Group 2 - Representatives from the three selected units shared their experiences, highlighting the comprehensive innovation service capabilities of the National Science Wenzhou Research Institute's CDMO platform, the marine biological manufacturing pilot platform's capabilities at Zhejiang Marine Development Research Institute, and the integrated "concept verification - pilot - small-scale production" platform at Hangzhou Chuanhua Technology City [2] - The joint notice from the Ministry of Industry and Information Technology and the National Development and Reform Commission aims to cultivate over 20 pilot capacity construction platforms by 2027, serving more than 200 enterprises and incubating over 400 products to support the transition from innovation to industrial application [2] - The demand for specialized pilot platforms is increasingly urgent due to policy incentives and market needs, as evidenced by discussions at the event regarding the challenges and considerations in building these platforms from an industry perspective [3]

Group 1 - The Chongqing Liangjiang New Area has gathered multiple pilot test platforms represented by companies like Boji Pharmaceutical, Boteng Pharmaceutical, and Huaguan Biotechnology, providing "one-stop" services for the acceleration of scientific research results into industrialization [1][3] - Pilot test platforms are comprehensive support platforms that facilitate the transition of research results from laboratory development to large-scale industrial production, playing a key role in the commercialization of innovative outcomes [3] - The Ministry of Industry and Information Technology and the National Development and Reform Commission aim to cultivate over 20 pilot test capability construction platforms by 2027, serving more than 200 companies and incubating over 400 products [3] Group 2 - Boji Pharmaceutical's subsidiary, Chongqing Boji Pharmaceutical Co., Ltd., focuses on high-tech barrier and high R&D cost complex injection drug development and production, with a platform that includes R&D laboratories, quality testing centers, and sterile injection production workshops [4] - The company has incubated 8 pharmaceutical enterprises to date and aims to assist more clients in completing multiple major complex injection drugs for the first time in China, as well as achieving international registration and market expansion [4] - Boteng Pharmaceutical, also located in the Water and Soil New City, provides one-stop service solutions for small molecule drugs, peptides, oligonucleotide drugs, protein and conjugate drugs, and cell and gene therapy drugs, covering the entire lifecycle from preclinical research to drug commercialization [4] Group 3 - The Liangjiang New Area is recognized as a core area for the development of the life and health industry, currently hosting 25 various platforms related to technical services, administrative regulation, industrial incubation, scientific innovation, and clinical services [5] - The area is continuously optimizing its industrial ecosystem and improving its service system to inject momentum into the collaborative innovation development of the biopharmaceutical industry chain [5]

Market Data - As of June 11, the Shanghai Composite Index rose by 0.52% to 3402.32 points, while the ChiNext Index increased by 1.21% to 2061.87 points [1] - U.S. stock indices collectively declined, with the S&P 500 down by 0.27% and the Nasdaq down by 0.5%, amid better-than-expected inflation data raising expectations for potential interest rate cuts by the Federal Reserve [1] - International oil prices saw significant increases, with light crude oil futures rising by $3.17 to $68.15 per barrel, a 4.88% increase, and Brent crude oil futures up by $2.90 to $69.77 per barrel, a 4.34% increase [1] Economic News - The first meeting of the China-U.S. economic consultation mechanism took place in London, where both sides reached a principled consensus on addressing economic concerns and enhancing cooperation [2][3] - China's stance on U.S.-China trade relations emphasizes mutual benefit and cooperation, with a clear rejection of trade wars [2] - The Chinese Ministry of Commerce reported that the recent discussions were professional and aimed at building trust and stability in economic relations [3] Automotive Industry - The National Certification and Accreditation Administration announced a pilot program for mandatory product certification in the automotive sector to enhance quality infrastructure for exports [5] - China is projected to export 5.859 million vehicles in 2024, maintaining its position as the world's largest automotive exporter, but will face increasing demands for product diversification and compliance with international regulations [5][6] Green Finance - A joint notice from multiple departments in Shanghai aims to enhance financial support for green projects, promoting the development of a green finance service platform and increasing the scale of green loans [7] Inflation Data - The U.S. Consumer Price Index (CPI) for May increased by 2.4% year-on-year, slightly below market expectations, while the core CPI rose by 2.8%, also below expectations [9]

Core Viewpoint - The Ministry of Industry and Information Technology and the National Development and Reform Commission have initiated a program to cultivate pilot-scale biomanufacturing capabilities, focusing on addressing gaps and pain points in the biomanufacturing sector [1] Group 1: Biomanufacturing Focus Areas - The initiative aims to develop pilot platforms for key product areas including food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations, promoting collaborative innovation across the industry chain [1] - Emphasis is placed on cultivating pilot platforms for new raw material development, particularly in lignocellulosic materials and one-carbon compounds (such as carbon monoxide and methanol) [1] - The program will also focus on establishing pilot platforms for plant chassis cells, which utilize genetically modified plant cells (such as tobacco, rice, and Taxus cells) to address emerging field gaps in biomanufacturing [1]